Evaluation of iron dosing according to iron demand in hemodialysis patients treated with Darbepoetin alfa
Not Applicable
- Conditions
- Patients treated with maintenance hemodialysis
- Registration Number
- JPRN-UMIN000015869
- Lead Sponsor
- Yokodai Central Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients with chronic inflammation, malignant disorder, severe congestive heart failure, respiratory organs, and liver disorder (2) Patients who are receiving dialysis modalities other than hemodialysis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (1) Hemoglobin and erythropoiesis-related indexes (2)Blood chemical examination including iron-related, inflammation, nutrition indexes (3)Required dose of Darbepoetin alfa (4)Hemodynamic parameters
- Secondary Outcome Measures
Name Time Method